Clinical Trial: Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Colorectal Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase Ib Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Patients With Unresectable, Locally Advanced, or Metastatic Non-Small Cell
Brief Summary:
The main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab.The study consists of a dose-finding stage followed by an expansion stage.
Read more